Company news
Spero Therapeutics, Inc. news in 2023
Spero Therapeutics, Inc.'s news releases, calls and decks from 2023, newest first.
Spero Therapeutics Announces Third Quarter 2023 Operating Results and Provides a Business Update
November 12, 2023
Spero Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
November 5, 2023
Spero Therapeutics Appoints Esther Rajavelu as Chief Financial Officer and Chief Business Officer
October 31, 2023
Spero Therapeutics Announces Second Quarter 2023 Operating Results and Provides a Business Update
August 9, 2023
Spero Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 PIVOT-PO Trial of Tebipenem HBr
July 30, 2023
Spero Therapeutics Appoints Sath Shukla as President & Chief Executive Officer
June 13, 2023
Spero Therapeutics Announces First Quarter 2023 Operating Results and Provides a Business Update
May 10, 2023
Spero Therapeutics to Provide Business Update and Report First Quarter 2023 Financial Results on Thursday, May 11, 2023
May 3, 2023
Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update
March 29, 2023
Spero Therapeutics Reschedules Fourth Quarter and Full Year 2022 Earnings Release and Conference Call to March 30, 2023
March 12, 2023
Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full Year 2022 Financial Results on Monday, March 13, 2023
March 5, 2023
Calls in 2023
- Spero Therapeutics (NASDAQ:SPRO) Q3 2023 Earnings Call
Nov 13, 2023
Transcript - Spero Therapeutics (NASDAQ:SPRO) Q2 2023 Earnings Call
Aug 10, 2023
Transcript - Spero Therapeutics (NASDAQ:SPRO) Q1 2023 Earnings Call
May 11, 2023
Transcript - Spero Therapeutics (NASDAQ:SPRO) Q4 2022 Earnings Call
Mar 30, 2023
Transcript
Decks in 2023
- Investor Presentation (January 2023)
Investor deck · 27 slides · Jan 9, 2023
- Corporate Update (January 2023)
Corporate update · 5 slides · Jan 9, 2023